human
cholin
dehydrogenas
chd
locat
inner
membran
mitochondria
primarili
liver
kidney
catalyz
oxid
cholin
glycin
betain
physiolog
role
regul
concentr
cholin
glycin
betain
blood
cell
cholin
import
regul
gene
express
biosynthesi
lipoprotein
membran
phospholipid
biosynthesi
neurotransmitt
acetylcholin
glycin
betain
play
import
role
primari
intracellular
osmoprotect
methyl
donor
biosynthesi
methionin
homocystein
requir
step
synthesi
ubiquit
methyl
donor
sadenosyl
methionin
recent
chd
gener
consider
medic
attent
due
associ
variou
human
patholog
includ
male
infertil
homocysteinuria
breast
cancer
metabol
syndrom
despit
renew
interest
biochem
character
enzym
lag
behind
due
difficulti
obtain
purifi
activ
stabl
enzym
review
articl
summar
medic
relev
physiolog
role
human
chd
highlight
biochem
knowledg
enzym
provid
analysi
base
comparison
protein
sequenc
bacteri
cholin
oxidas
structur
biochem
inform
avail
human
cholin
dehydrogenas
chd
ec
nuclearencod
mitochondri
enzym
involv
cholin
metabol
accord
ncbi
gene
databas
gene
code
chd
identifi
chromosom
gene
locat
studi
haubrich
et
al
human
tissu
enzymat
activ
chd
detect
mainli
kidney
lower
level
liver
tissu
like
blood
spleen
heart
display
low
chd
activ
wherea
detect
activ
report
muscl
fat
tissu
chd
also
present
bacteria
fungi
mammal
fig
notabl
absent
plant
ironsulfur
cholin
monooxygenas
cmo
ec
identifi
instead
chd
eukaryot
organ
associ
inner
mitochondri
membran
matrix
side
homolog
protein
prokaryot
sourc
associ
cytosol
side
cell
membran
medic
point
view
human
chd
interest
due
associ
variou
patholog
includ
male
infertil
homocysteinuria
cancer
enzym
also
readili
metabol
cholin
latter
administ
pharmacolog
agent
therebi
limit
potenti
therapeut
use
great
attent
also
direct
bacteri
chd
medic
biotechnolog
fundament
reason
medic
interest
primarili
due
fact
prokaryot
enzym
play
import
role
abil
bacteria
grow
environ
high
salin
human
infect
site
thu
repres
potenti
pharmaceut
target
combin
therapi
biotechnolog
applic
primarili
focu
genet
engin
glycin
betain
biosynthesi
cholin
provid
osmot
stress
resist
econom
relev
plant
detect
cholin
deriv
biolog
fluid
biochem
interest
stem
mainli
comparison
catalyt
strategi
util
oxid
cholin
three
type
enzym
carri
reaction
chd
cmo
cholin
oxidas
cho
ec
scheme
organ
oxid
cholin
use
chd
cmo
second
enzym
ie
betain
aldehyd
dehydrogenas
badh
ec
respons
oxid
betain
aldehyd
glycin
betain
contrast
cho
catalyz
step
oxid
cholin
betain
aldehyd
betain
aldehyd
glycin
betain
despit
consider
interest
human
prokaryot
chd
biochem
character
enzym
significantli
lag
behind
medic
biotechnolog
applic
due
high
instabl
enzym
remov
inner
mitochondri
membran
prevent
obtain
activ
stabl
purifi
enzym
structuralfunct
studi
review
articl
present
physiolog
role
medic
relev
cellular
local
human
chd
provid
summari
attempt
difficulti
purifi
chd
summar
avail
biochem
knowledg
enzym
introduc
comparison
protein
sequenc
chd
bacteri
cho
structur
biochem
inform
avail
model
structur
chd
built
known
structur
cho
previous
obtain
xray
crystallographi
also
present
human
chd
catalyz
oxid
cholin
betain
aldehyd
oxid
glycin
betain
second
enzym
badh
enzymat
reaction
achiev
dual
physiolog
role
regul
concentr
free
cholin
cell
bodili
fluid
synthes
metabolit
relev
osmoprotect
methyl
process
fig
sinc
osmoprotect
role
glycin
betain
studi
regard
regul
cell
volum
increas
stabil
intracellular
macromolecul
human
mammal
glycin
betain
play
import
osmoprotect
role
kidney
shown
increas
concentr
dehydr
liver
regul
hepatocellular
hydrat
fatti
liver
often
observ
consequ
low
intak
cholin
diet
due
like
decreas
concentr
phosphatydilcholin
necessari
synthesi
verylowdens
lipoprotein
vldl
rodent
establish
fatti
liver
develop
fed
low
cholin
diet
interest
note
human
anim
plant
mani
microorgan
share
use
glycin
betain
primari
tool
protect
variou
form
stress
besid
osmot
pressur
due
swift
variat
concentr
osmolit
cellular
environ
includ
high
low
temperatur
reactiv
oxygen
speci
form
cellular
insult
human
mammal
glycin
betain
play
also
import
role
methyl
group
donor
involv
exampl
methyl
homocystein
methionin
scheme
concentr
glycin
betain
thu
consid
import
metabol
syndrom
lipid
disord
diabet
vascular
diseas
develop
embryo
regul
concentr
cholin
tissu
blood
import
cholin
play
key
role
differ
pathway
cholin
involv
epigenet
regul
gene
express
dna
methyl
shown
exampl
global
hypomethyl
hepat
dna
rat
fed
low
cholin
diet
biosynthesi
lipoprotein
membran
phospholipid
biosynthesi
neurotransmitt
acetylcholin
scheme
therefor
import
integr
cell
membran
lipid
metabol
nerv
function
cholin
consid
import
nutrient
fetal
brain
develop
shown
exampl
differ
rate
develop
hippocampu
fetal
brain
rodent
model
case
low
high
matern
cholin
intak
cholin
constitu
phospholipid
involv
signal
transduct
phosphatidylcholin
plasmalogen
phospholipid
platelet
activ
factor
metabol
cholin
also
interrel
metabol
folat
shown
folat
content
liver
cholin
defici
rat
decreas
compar
control
rat
scheme
best
knowledg
util
cholin
xenobiot
oxygenas
present
liver
exampl
cytochrom
flavin
monooxygenas
describ
literatur
would
interest
evalu
whether
enzym
besid
chd
oxid
cholin
past
year
attent
human
chd
involv
variou
patholog
grown
consider
tabl
enzym
associ
male
infertil
multipl
independ
studi
johnson
et
al
establish
correl
activ
chd
male
fertil
delet
correspond
gene
mice
absenc
chd
activ
result
diminish
sperm
motil
greatli
affect
reproduct
abil
mice
one
eleven
chd
mice
abl
reproduc
mitochondri
alter
describ
testi
well
liver
kidney
heart
polymorph
human
gene
recent
identifi
associ
decreas
activ
human
chd
alter
human
sperm
eg
arg
impair
human
chd
activ
associ
homocysteinuria
accumul
homocystein
repres
independ
risk
factor
cardiovascular
diseas
observ
consist
glycin
betain
main
methyl
donor
convers
homocystein
methionin
catalyz
enzym
betainehomocystein
methyltransferas
scheme
biosynthesi
methionin
import
metabol
methyl
group
necessari
synthesi
wide
use
methyl
donor
sadenosylmethionin
sam
scheme
populationbas
studi
monitor
blood
level
cholin
metabolit
glycin
betain
relat
compon
metabol
syndrom
percent
bodi
fat
blood
pressur
serum
lipid
etc
correl
found
high
concentr
cholin
low
concentr
glycin
betain
blood
highrisk
profil
cardiovascular
diseas
shown
amount
cholin
glycin
betain
suppli
diet
signific
effect
blood
concentr
compound
therefor
author
propos
alter
concentr
cholin
glycin
betain
blood
aris
malfunct
mitochondri
biosynthesi
glycin
betain
rather
dietari
pattern
human
chd
import
catabol
util
cholin
latter
administ
pharmacolog
agent
cholin
involv
stimul
cholinerg
neuron
activ
scheme
restor
phosphatidylcholin
level
neuron
membran
thu
display
neuroprotect
action
relev
diseas
memori
cognit
deficit
studi
suggest
mechan
neuroprotect
associ
suppli
exogen
cholin
base
fact
case
cholin
defici
brain
may
degrad
membran
phospholipid
neuron
order
recycl
cholin
product
acetylcholin
scheme
chd
predominantli
activ
two
main
detoxifi
organ
liver
kidney
determin
halflif
cholin
blood
studi
h
methylcholin
administ
intraven
guinea
pig
main
metabolit
cholin
detect
blood
shown
glycin
betain
kidney
liver
remov
administ
dose
within
min
follow
inject
rapid
turnov
cholin
administ
drug
clearli
desir
sinc
limit
therapeut
action
requir
administr
higher
dose
recent
administr
cholin
pharmacolog
agent
evolv
use
cytidin
diphosphocholin
cholin
donor
compound
readili
hydrolyz
intestin
yield
cholin
cytidin
rapidli
absorb
yield
increas
plasmat
level
compound
compound
cross
bloodbrain
barrier
util
resynthesi
cytidin
diphosphocholin
scheme
brain
cytidin
diphosphocholin
show
promis
result
clinic
trial
stroke
therapi
memori
impair
elderli
recoveri
brain
injuri
alzheim
diseas
glaucoma
gave
improv
bradykinesia
muscular
rigid
cytidin
diphosphocholin
sold
dietari
supplement
unit
state
prescript
drug
japan
europ
recent
populationbas
studi
show
metabol
oxid
cholin
relat
risk
develop
breast
cancer
conclud
dietari
intak
higher
dose
cholin
women
relat
lower
risk
develop
breast
cancer
studi
increas
risk
factor
breast
cancer
also
associ
polymorph
human
gene
code
chd
curious
polymorph
link
alter
sperm
mobil
pattern
alter
mitochondri
morpholog
human
sperm
associ
steril
studi
prognost
biomark
breast
cancer
identifi
express
chd
among
three
human
gene
control
estrogen
show
strong
predictor
outcom
treatment
tamoxifen
earlystag
er
posit
breast
cancer
patient
chd
origin
report
genbank
access
number
subcellular
local
mammalian
chd
studi
rat
experi
gradient
centrifug
shown
associ
enzym
inner
membran
mitochondria
ntermin
sequenc
chd
extract
rat
liver
mitochondria
demonstr
matur
chd
begin
amino
acid
studi
suggest
chd
contain
ntermin
cleavabl
mitochondri
target
presequ
amino
acid
hypothes
two
cleavag
site
may
present
recognit
process
mitochondri
process
proteas
inner
membran
proteas
data
agreement
notion
mitochondri
protein
encod
nuclear
gene
synthes
cytosol
ribosom
includ
primari
structur
specif
leader
sequenc
import
mitochondria
local
either
outer
inner
membran
intermembran
space
matrix
base
studi
presum
human
chd
similarli
local
inner
mitochondri
membran
glucosemethanolcholin
enzym
oxidoreductas
superfamili
chd
one
enzym
origin
group
glucosemethanolcholin
gmc
enzym
oxidoreductas
superfamili
base
primari
structur
align
superfamili
enzym
establish
analysi
protein
sequenc
drosophila
melanogast
glucos
dehydrogenas
escherichia
coli
chd
aspergillu
niger
glucos
oxidas
tabl
medic
relev
human
chd
male
infertil
homocysteinuria
metabol
syndrom
cholin
pharmacolog
agent
breast
cancer
hansenula
polymorpha
methanol
oxidas
highlight
fact
protein
homolog
member
famili
flavoenzym
catalyz
oxid
varieti
alcohol
differ
chemic
structur
year
sever
enzym
ad
superfamili
crystal
structur
eight
member
current
avail
includ
aglobiformi
cho
anig
glucos
oxidas
brevibacterium
sterolicum
cholesterol
oxidas
phanerochaet
chrysosporium
cellobios
dehydrogenas
tramet
ochracea
pleurotu
eryngii
arylalcohol
oxidas
aspergillu
oryza
format
oxidas
mesorhizobium
loti
pyridoxin
despit
share
limit
sequenc
similar
enzym
share
similar
overal
structur
highli
conserv
catalyt
site
recent
review
see
fig
surprisingli
major
differ
present
substrat
domain
enzym
primarili
alcohol
substrat
structur
unrel
given
difficulti
obtain
purifi
activ
stabl
enzym
structur
inform
deriv
xray
crystallographi
avail
chd
howev
base
similar
activ
site
architectur
avail
biochem
data
member
superfamili
character
depth
includ
cho
reason
expect
chd
util
catalyt
mechan
oxid
cholin
similar
cho
alcohol
oxid
occur
hydrid
transfer
illustr
later
section
sever
amino
acid
whose
role
elucid
cho
sitedirect
mutagenesi
conserv
human
chd
allow
propos
similar
role
residu
activ
site
membranebound
dehydrogenas
character
chd
varieti
cellular
sourc
far
limit
fact
difficult
obtain
stabl
activ
highli
purifi
enzym
remov
cellular
locat
associ
enzym
membran
repres
challeng
purif
vitro
stabil
enzym
awar
one
report
partial
purif
recombin
human
chd
express
ecoli
describ
phd
thesi
studi
final
enzym
yield
low
mg
purifi
chd
l
bacteri
cell
cultur
limit
stabil
purifi
enzym
prevent
character
human
chd
partial
character
cofactor
gener
antibodi
biochem
kinet
properti
chd
determin
experi
crude
mitochondri
fraction
purifi
enzym
primarili
rat
liver
studi
carri
oyster
mitochondri
fraction
without
purif
enzym
first
attempt
obtain
purifi
enzym
conduct
william
et
al
succeed
isol
chd
rat
liver
upon
extract
choleat
later
recogn
howev
protocol
yield
solubl
form
enzym
rather
dispers
insolubl
particl
rendina
singer
develop
new
extract
method
chd
rat
liver
base
use
naja
naja
venom
sourc
phospholipas
solubil
chd
mitochondri
membran
without
purif
protein
partial
purif
rat
liver
mitochondria
report
tsuge
et
al
upon
extract
deterg
triton
follow
deaesepharos
cholinesepharos
affin
column
chromatographi
howev
prepar
enzym
analyz
sdspage
show
three
band
demonstr
poor
vitro
stabil
ameyama
et
al
partial
purifi
enzym
dog
liver
less
yield
despit
multipl
effort
purifi
chd
variou
eukaryot
sourc
problem
associ
scarc
solubl
vitro
stabil
mammalian
enzym
still
major
challeng
tabl
purif
chd
prokaryot
sourc
reveal
challeng
similar
encount
mammalian
enzym
protocol
partial
purif
chd
paeruginosa
report
author
state
limit
stabil
enzym
copurif
second
enzym
biosynthet
pathway
badh
byproduct
protocol
attempt
obtain
pure
prepar
chd
perform
group
studi
recombin
protein
halomona
elongata
express
ecoli
partial
purifi
homogen
treatment
ammonium
sulfat
follow
deaesepharos
column
chromatographi
subsequ
partial
purif
recombin
chd
ecoli
carri
rajan
et
al
appli
purif
protocol
develop
chd
helongata
tsuge
et
al
note
studi
purif
rat
liver
chd
characterist
report
thu
far
obtain
use
rel
crude
prepar
highli
purifi
prepar
urgent
prioriti
field
illustr
previou
section
remain
true
littl
known
biochem
properti
chd
report
human
enzym
genet
studi
isol
determin
enzymat
activ
tissu
homogen
moreov
limit
biochem
knowledg
chd
acquir
either
mitochondri
fraction
enrich
enzym
partial
purifi
unstabl
prepar
enzym
cofactor
content
chd
investig
unequivoc
evid
ident
avail
base
presenc
glycin
box
gxgxxg
nterminu
protein
propos
fad
cofactor
chd
would
agre
well
known
gmc
member
contain
fad
cofactor
tabl
howev
direct
evid
presenc
flavin
report
partial
purifi
prepar
chd
enzym
paeruginosa
dog
contain
glycin
box
propos
use
pyrroloquinolin
quinon
pqq
instead
flavin
awar
two
phd
these
show
uvvis
absorb
spectra
partial
purifi
chd
ecoli
peak
nm
region
consist
presenc
flavin
cofactor
character
cofactor
report
base
high
number
cystein
residu
locat
eukaryot
enzym
mitochondri
inner
membran
next
respiratori
chain
earli
studi
presenc
labil
sulfur
group
often
assum
introduct
mani
studi
enzym
contain
iron
sulfur
cluster
howev
evid
avail
conclud
unequivoc
ironsulfur
cluster
present
chd
notion
enzym
partial
purifi
contribut
rais
question
whether
contamin
protein
may
instead
harbor
report
cofactor
electron
acceptor
reaction
cholin
oxid
catalyz
chd
known
report
oxygen
prefer
electron
acceptor
even
though
enzym
abl
util
commonli
use
electron
acceptor
enzymat
assay
chd
variou
cellular
sourc
phenazin
methosulph
pm
electron
acceptor
cytochrom
c
ferricyanid
test
rendina
singer
barrett
et
al
rat
chd
extract
mitochondria
highest
enzymat
activ
measur
presenc
pm
propos
enzym
util
coenzym
q
electron
acceptor
base
cellular
local
enzym
close
complex
ii
inner
mitochondri
membran
investig
necessari
valid
hypothesi
substrat
specif
partial
purifi
rat
liver
chd
investig
tsuge
et
al
enzymat
activ
determin
cholin
betain
aldehyd
substrat
agreement
data
chd
helongata
also
use
betain
aldehyd
substrat
besid
cholin
vitro
inhibit
partial
purifi
rat
liver
chd
observ
monoethanolamin
semicarbazid
lesser
extent
lmalat
glycin
betain
preliminari
kinet
studi
partial
purifi
chd
rat
liver
demonstr
increas
specif
activ
enzym
cholin
alkalin
ph
steadi
state
kinet
character
cholin
pm
electron
acceptor
yield
k
valu
mm
cholin
allow
propos
pingpong
bibi
steadi
state
kinet
mechan
partial
purifi
rat
chd
enzym
helongata
kinet
paramet
determin
ph
fix
concentr
either
pm
oxygen
electron
acceptor
thu
inform
steadi
state
kinet
mechan
bacteri
chd
avail
gener
homolog
model
human
chd
swissmodel
server
use
cho
aglobiformi
templat
two
enzym
share
sequenc
ident
fig
catalyz
oxid
reaction
cholin
activ
site
mutant
cho
replac
alanin
pdb
use
instead
wild
type
enzym
sinc
flavin
latter
crystallograph
structur
present
unusu
c
adduct
ntermin
intern
extra
peptid
present
sequenc
chd
delet
silico
construct
homolog
model
absent
cho
two
homolog
model
human
chd
gener
use
pyridoxin
pdb
arylalcohol
oxidas
pdb
templat
yield
structur
practic
superimpos
gener
use
cho
data
shown
fig
illustr
overal
structur
activ
site
homolog
model
human
chd
superimpos
tridimension
structur
anoth
activ
site
mutant
cho
ie
overal
structur
model
human
chd
appear
similar
conserv
overal
fold
gmc
superfamili
member
fig
highlight
transmembran
helix
domain
welldefin
membranebind
domain
therefor
hypothes
human
chd
integr
membran
protein
possibl
way
associ
chd
inner
mitochondri
membran
consid
exampl
insert
short
hydrophob
anchor
n
termin
region
protein
membran
similar
c
termin
anchor
describ
human
monoamin
oxidas
b
altern
hydrophob
interact
expos
hydrophob
region
protein
membran
ionic
interact
posit
charg
residu
polar
head
membran
phospholipid
given
difficulti
encount
extract
chd
membran
also
possibl
coval
attach
protein
phospholipid
case
rodent
neural
cell
adhes
molecul
ncam
homolog
model
human
chd
allow
us
propos
local
relev
polymorph
associ
male
infertil
increas
risk
factor
breast
cancer
surfac
enzym
fig
replac
hydrophob
residu
posit
charg
one
would
local
alter
polar
enzym
surfac
perhap
decreas
stabil
enzym
contrast
chd
cho
aglobiformi
extens
investig
structur
biochem
kinet
mechanist
properti
primarili
stem
fact
oxidas
solubl
protein
purifi
high
yield
stabl
activ
form
offer
opportun
compar
contrast
amino
acid
sequenc
human
chd
bacteri
cho
two
enzym
catalyz
oxid
substrat
hypothes
residu
conserv
activ
site
two
enzym
similar
role
catalysi
align
amino
acid
sequenc
human
chd
aglobiformi
cho
return
ident
similar
residu
shown
fig
sever
activ
site
residu
previous
investig
cho
use
sitedirect
mutagenesi
biochem
structur
mechanist
tool
conserv
chd
includ
tabl
fig
thu
propos
chd
particip
substrat
bind
posit
subsequ
hydrid
transfer
modul
polar
activ
site
stabil
transit
state
oxid
cholin
betain
aldehyd
import
cholin
fad
oxid
three
residu
investig
activ
site
cho
notabl
differ
chd
ie
replac
chd
respect
site
coval
attach
flavin
cho
fig
align
amino
acid
sequenc
human
chd
aglobiformi
cho
main
gap
box
blue
glycin
box
contour
red
activ
site
residu
cho
conserv
chd
highlight
red
star
activ
site
residu
cho
conserv
chd
highlight
blue
star
allow
propos
flavin
present
chd
would
coval
link
protein
contribut
optim
overal
turnov
cho
requir
finetun
four
consecut
halfreact
oxid
cholin
betain
aldehyd
betain
aldehyd
glycin
betain
follow
oxid
flavin
oxygen
sinc
second
enzym
ie
badh
catalyz
oxid
betain
aldehyd
glycin
betain
finetun
multipl
halfreact
requir
chd
cho
provid
nonpolar
side
chain
requir
guid
oxygen
proxim
c
atom
flavin
subsequ
react
reduc
flavin
conclus
deriv
sitedirect
mutagenesi
studi
replac
either
threonin
alanin
interestingli
alanin
present
lieu
chd
fig
tabl
allow
propos
lack
valin
may
partli
respons
low
reactiv
chd
toward
oxygen
anoth
differ
emerg
comparison
amino
acid
sequenc
oxidas
dehydrogenas
presenc
chd
extra
peptid
nterminu
posit
present
cho
fig
extra
peptid
nterminu
chd
may
relev
import
target
enzym
matrix
mitochondria
would
agre
well
observ
matur
rat
liver
chd
mitochondria
lack
first
amino
acid
ntermin
end
second
extra
peptid
length
residu
may
respons
membran
associ
chd
although
evid
avail
back
hypothesi
stage
fig
provid
timelin
major
develop
chd
sinc
first
report
oxid
cholin
rat
liver
mammalian
enzym
respons
oxid
cholin
connect
mitochondri
respiratori
chain
recogn
first
partial
purif
chd
carri
difficulti
encount
purif
mammalian
subsequ
prokaryot
enzym
led
preliminari
biochem
character
chd
progress
fade
interest
biochemist
toward
enzym
sinc
howev
human
chd
receiv
consider
interest
medic
commun
due
involv
enzym
number
human
patholog
includ
male
infertil
homocysteinuria
breast
cancer
metabol
syndrom
biochem
character
enzym
therebi
requir
gain
knowledg
molecular
base
link
chd
patholog
exampl
vitro
structur
kinet
character
chd
variant
associ
polymorph
would
fundament
provid
biochem
rational
explain
malfunct
enzym
may
due
sever
factor
protein
aggreg
increas
protein
instabl
decreas
enzymat
activ
limit
access
substrat
enzym
activ
site
etc
date
biochem
character
chd
sever
hamper
lack
obtain
stabl
activ
highli
purifi
enzym
either
mammalian
prokaryot
sourc
sever
strategi
develop
enzym
express
difficult
protein
associ
membran
choic
chd
could
use
yeast
pichia
pastori
allow
import
local
recombin
enzym
mitochondria
protocol
success
employ
human
liver
monoamin
oxidas
approach
overexpress
recombin
human
chd
e
coli
could
exploit
use
strain
select
high
toler
toward
membran
protein
altern
fusion
protein
chd
maltosebind
protein
type
sumo
small
ubiquitinrel
modifi
protein
could
engin
increas
solubl
human
chd
latter
approach
success
bacteri
express
protein
flap
sever
acut
respiratori
syndrom
coronaviru
sarscov
membran
protein
thu
develop
success
protocol
purif
stabl
activ
enzym
absolut
requir
advanc
knowledg
old
import
enzym
